Indegene Limited announced the appointment of Mr. Neeraj Bharadwaj (DIN: 01314963) as a Non-Executive Independent Director. The Board of Directors approved this appointment on December 19, 2025, based on the recommendation of the Nomination and Remuneration Committee. This appointment is for a term of five years, effective from January 25, 2026, to January 24, 2031, subject to shareholder approval via Postal Ballot. Mr. Bharadwaj is not debarred from holding the office of Director by any SEBI order or other authority. Mr. Bharadwaj holds a Bachelor of Science in Economics with a specialization in Finance from the University of Pennsylvania and an MBA in Management from Harvard University. He possesses extensive experience in private equity, investment management, and strategic leadership, having managed significant investments across various sectors. His academic background and professional experience underscore his expertise in finance, business strategy, and corporate governance. He has also held prominent leadership and advisory roles in global and national organizations. The Board also approved allotments under the ESOP Plan 2020 and RSU Plan 2020. The disclosure regarding Mr. Bharadwaj's appointment, as required by SEBI LODR Regulations, is detailed in Annexure-I. This information is also available on the company's website.